MINDWAYS SOFTWARE, INC.

Mindways Software develops FDA-cleared software solutions for quantitative CT (QCT) bone densitometry. The company enables healthcare providers to measure bone density directly from existing CT scans, offering both dedicated bone density testing and dual-use opportunistic screening applications. Product families include CliniQCT (clinical-grade bone density measurement), QCT Pro (advanced analysis platform), and BIT (bone imaging tools). These solutions are designed for orthopedic screening, osteoporosis detection, and fracture risk assessment in clinical and research settings. Mindways' approach allows facilities with existing CT infrastructure to add FDA-cleared, reimbursable bone densitometry services without additional radiation exposure when using opportunistic screening. The company supports integration with dual-energy X-ray absorptiometry (DXA) programs for comprehensive bone health assessment. Mindways maintains headquarters in Austin, Texas, with additional offices in Kiel, Germany, and Lebanon, serving global clinical and research markets.